Etoricoxib Auxilto

Symptomatic relief of OA; ankylosing spondylitis (AS). RA. Pain & inflammation signs associated w/ acute gouty arthritis. Acute pain including that related to primary dysmenorrhea & minor dental procedures.

OA 30 mg once daily. Max: 60 mg daily. RA & AS 60 mg once daily. Max: 90 mg daily. Acute gouty arthritis 120 mg once daily. Max: 120 mg daily. Max duration of treatment: 8 days. Acute pain 90 or 120 mg once daily. Max: 120 mg daily. Max duration of treatment: 8 days. Primary dysmenorrhea 120 mg once daily. Max: 120 daily. Post-op dental pain 90 mg once daily. Max: 90 mg daily. Max duration of treatment: 3 days. Hepatic insufficiency: Child-Pugh score 7-9 Max: 60 mg every other day, score 5-6 Max: 60 mg once daily.

May be taken with or without food.

Hypersensitivity. Patients w/ CHF (NYHA II-IV); established ischemic heart disease, peripheral arterial disease &/or cerebrovascular disease (including patients who have recently undergone CABG or angioplasty); HTN whose BP has not been adequately controlled; active peptic ulceration or GI bleeding; who have developed signs of asthma, acute rhinitis, nasal polyps, angioneurotic oedema or urticaria following administration of ASA or other NSAIDs; inflammatory bowel disease. Patients w/ estimated CrCl <30 mL/min. Severe hepatic dysfunction (Child-Pugh score >9). Pregnancy & lactation. Childn & adolescents <16 yr.

Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)

M01AH05 - etoricoxib ; Belongs to the class of non-steroidal antiinflammatory and antirheumatic products, coxibs.

POM